EUVIMEDEUVIMED entdecken
Crossref

GLP‐1 Receptor Agonist Effect on Disease Severity in Idiopathic Subglottic Stenosis

Ronit E Malka iD, Sam Collins, Vasiliki Triantafillou iD, Niloufar Saeedi iD, Lee M Akst iD, Simon R Best, Kevin Motz iD, Alexander T Hillel iD

Otolaryngology–Head and Neck Surgery · 2026

DOI: 10.1002/ohn.70327 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2026. Verfasst von Ronit E Malka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Laryngostenosis, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) have been associated with systemic anti‐inflammatory effects in addition to weight loss. Their effect on idiopathic subglottic stenosis (iSGS) has not been evaluated. This study aimed to characterize the effect of GLP‐1RAs on surgery‐free interval (SFI) in iSGS. Study Design Retrospective cohort study.

Setting

Single‐institution academic center.

Methods

Two hundred and twenty‐three iSGS patients were reviewed for GLP‐1RA usage. SFI, and secondary measures of weight loss, body mass index (BMI), and Cotton‐Myer grade before and after starting GLP‐1RAs were analyzed. Patients were excluded if GLP‐1RAs were begun prior to establishing SFI, or if serial intralesional steroid injection or endoscopic or open cricotracheal resection were performed. Statistical comparisons for SFI and weight loss were performed with paired t tests, univariate, and multiple linear regression, and a generalized linear mixed‐effects model was used to compare Cotton‐Myer grades, with a threshold for significance of α = .05.

Results

Thirty‐two patients (14%) were taking GLP‐1RAs, with 14 meeting the inclusion criteria. SFI increased by a mean of 10.7 months, or 68.5% ( P = .001). Patients lost 39 pounds on average, with a mean BMI decrement of 6.8 points ( P < .001). There was no appreciable correlation between weight loss, initial BMI, and SFI on multiple linear regression ( P = .92, adjusted R 2 = −0.16) or univariate linear regression between SFI and weight loss ( P = .98, R 2 < 0.001) or BMI ( P = .72, R 2 = 0.01). There was no difference in Cotton‐Myer grade at the time of surgery between patients before and after starting therapy ( P = .44).

Conclusion

GLP‐1RA therapy increases SFI in iSGS independent of initial BMI or weight loss. Level of Evidence IV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LaryngostenosisGlucagon-Like Peptide-1 Receptor AgonistsHumansFemaleRetrospective StudiesMaleSeverity of Illness IndexMiddle AgedWeight LossTreatment OutcomeAgedBody Mass Index

Stichwörter der Autor:innen

GLP‐1 receptor agonistairway fibrosisidiopathic subglottic stenosis

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA.

ORCID-Profile: Ronit E Malka, Vasiliki Triantafillou, Niloufar Saeedi, Lee M Akst, Kevin Motz, Alexander T Hillel

Zitieren

APA

Malka, R. E., Collins, S., Triantafillou, V., Saeedi, N., Akst, L. M., Best, S. R., Motz, K., & Hillel, A. T. (2026). GLP‐1 Receptor Agonist Effect on Disease Severity in Idiopathic Subglottic Stenosis. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.70327

Vancouver

Malka RE, Collins S, Triantafillou V, Saeedi N, Akst LM, Best SR, et al. GLP‐1 Receptor Agonist Effect on Disease Severity in Idiopathic Subglottic Stenosis. Otolaryngology–Head and Neck Surgery. 2026. doi:10.1002/ohn.70327

BibTeX
@article{Malka2026,
  author = {Malka, Ronit E and Collins, Sam and Triantafillou, Vasiliki and Saeedi, Niloufar and Akst, Lee M and Best, Simon R and Motz, Kevin and Hillel, Alexander T},
  title = {GLP‐1 Receptor Agonist Effect on Disease Severity in Idiopathic Subglottic Stenosis},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2026},
  doi = {10.1002/ohn.70327}
}
Kostenlos starten →